See 20% EBITDA growth in FY14: Alembic Pharma
Aug 07, 2013 at 15:50
Search Videos
The recent correction in Indian equities – on the back of a raft of bad news and relatively attractiveness of peers like China – has discounted most of the bad news into the price and investors should now start looking at fresh opportunities, acc...
Source : CNBC-TV18

Share this video with Friends

Members: 3,614,535

Tech Mahindra...

if that is confirmed ,then it...>

Posted by: bullguru2700      At: 03 May 2015 09:20      Category: Tech Mahindra


Reliance accumulate on all dip...>

Posted by: proline70      At: 04 May 2015 14:20      Category: index
Advances & Declines
S&P BSE Auto18656.34321.84
S&P BSE BANKEX21224.17193.29
Bank Nifty18507.70169.60
S&P BSE Capital Goods16689.11170.11
S&P BSE Consumer Durables10550.11172.48
S&P BSE FMCG8368.1416.06
S&P BSE Healthcare16567.39380.88
S&P BSE IT11501.95170.35
S&P BSE Metals9975.60174.63
S&P Oil & Gas9552.80349.35
S&P BSE PSU7809.49243.40
S&P BSE TECk5905.21109.30
S&P BSE Small Cap11177.08233.05
S&P BSE Mid-Cap10553.91137.62
CNX Midcap12965.10275.50